ArticleJournal of pharmaceutical analysis2026

Screening of tyrosine phosphatase SHP2 (PTPN11) inhibitors from natural products with therapeutic potential for receptor tyrosine kinase-driven cancer.

Lingfeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.